Literature DB >> 25702278

Dystrophin genotype-cardiac phenotype correlations in Duchenne and Becker muscular dystrophies using cardiac magnetic resonance imaging.

Animesh Tandon1, John L Jefferies1, Chet R Villa1, Kan N Hor2, Brenda L Wong3, Stephanie M Ware4, Zhiqian Gao1, Jeffrey A Towbin1, Wojciech Mazur5, Robert J Fleck6, Joshua J Sticka1, D Woodrow Benson7, Michael D Taylor8.   

Abstract

Duchenne and Becker muscular dystrophies are caused by mutations in dystrophin. Cardiac manifestations vary broadly, making prognosis difficult. Current dystrophin genotype-cardiac phenotype correlations are limited. For skeletal muscle, the reading-frame rule suggests in-frame mutations tend to yield milder phenotypes. We performed dystrophin genotype-cardiac phenotype correlations using a protein-effect model and cardiac magnetic resonance imaging. A translational model was applied to patient-specific deletion, indel, and nonsense mutations to predict exons and protein domains present within truncated dystrophin protein. Patients were dichotomized into predicted present and predicted absent groups for exons and protein domains of interest. Development of myocardial fibrosis (represented by late gadolinium enhancement [LGE]) and depressed left ventricular ejection fraction (LVEF) were compared. Patients (n = 274) with predicted present cysteine-rich domain (CRD), C-terminal domain (CTD), and both the N-terminal actin-binding and cysteine-rich domains (ABD1 + CRD) had a decreased risk of LGE and trended toward greater freedom from LGE. Patients with predicted present CTD (exactly the same as those with in-frame mutations) and ABD1 + CRD trended toward decreased risk of and greater freedom from depressed LVEF. In conclusion, genotypes previously implicated in altering the dystrophinopathic cardiac phenotype were not significantly related to LGE and depressed LVEF. Patients with predicted present CRD, CTD/in-frame mutations, and ABD1 + CRD trended toward milder cardiac phenotypes, suggesting that the reading-frame rule may be applicable to the cardiac phenotype. Genotype-phenotype correlations may help predict the cardiac phenotype for dystrophinopathic patients and guide future therapies.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25702278      PMCID: PMC5568575          DOI: 10.1016/j.amjcard.2015.01.030

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  28 in total

1.  Detection of progressive cardiac dysfunction by serial evaluation of circumferential strain in patients with Duchenne muscular dystrophy.

Authors:  Sean C Hagenbuch; William M Gottliebson; Janaka Wansapura; Wojciech Mazur; Robert Fleck; D Woodrow Benson; Kan N Hor
Journal:  Am J Cardiol       Date:  2010-03-30       Impact factor: 2.778

2.  Patterns of left ventricular remodeling in patients with Duchenne Muscular Dystrophy: a cardiac MRI study of ventricular geometry, global function, and strain.

Authors:  Wojciech Mazur; Kan N Hor; Joshua T Germann; Robert J Fleck; Hussein R Al-Khalidi; Janaka P Wansapura; Eugene S Chung; Michael D Taylor; John L Jefferies; D Woodrow Benson; William M Gottliebson
Journal:  Int J Cardiovasc Imaging       Date:  2011-01-08       Impact factor: 2.357

3.  Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects.

Authors:  Marta Diegoli; Maurizia Grasso; Valentina Favalli; Alessandra Serio; Fabiana Isabella Gambarin; Catherine Klersy; Michele Pasotti; Emanuela Agozzino; Laura Scelsi; Alessandra Ferlini; Oreste Febo; Giovanni Piccolo; Luigi Tavazzi; Jagat Narula; Eloisa Arbustini
Journal:  J Am Coll Cardiol       Date:  2011-08-23       Impact factor: 24.094

4.  Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort.

Authors:  Kevin M Flanigan; Diane M Dunn; Andrew von Niederhausern; Payam Soltanzadeh; Eduard Gappmaier; Michael T Howard; Jacinda B Sampson; Jerry R Mendell; Cheryl Wall; Wendy M King; Alan Pestronk; Julaine M Florence; Anne M Connolly; Katherine D Mathews; Carrie M Stephan; Karla S Laubenthal; Brenda L Wong; Paula J Morehart; Amy Meyer; Richard S Finkel; Carsten G Bonnemann; Livija Medne; John W Day; Joline C Dalton; Marcia K Margolis; Veronica J Hinton; Robert B Weiss
Journal:  Hum Mutat       Date:  2009-12       Impact factor: 4.878

Review 5.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

6.  Left ventricular dysfunction in duchenne muscular dystrophy and genotype.

Authors:  Mahi L Ashwath; Irwin B Jacobs; Carol A Crowe; Ravi C Ashwath; Dennis M Super; Robert C Bahler
Journal:  Am J Cardiol       Date:  2014-05-02       Impact factor: 2.778

7.  Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study.

Authors:  Kan N Hor; Janaka Wansapura; Larry W Markham; Wojciech Mazur; Linda H Cripe; Robert Fleck; D Woodrow Benson; William M Gottliebson
Journal:  J Am Coll Cardiol       Date:  2009-04-07       Impact factor: 24.094

8.  An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus.

Authors:  A P Monaco; C J Bertelson; S Liechti-Gallati; H Moser; L M Kunkel
Journal:  Genomics       Date:  1988-01       Impact factor: 5.736

9.  Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up.

Authors:  Francesca Magri; Alessandra Govoni; Maria Grazia D'Angelo; Roberto Del Bo; Serena Ghezzi; Gandossini Sandra; Anna Carla Turconi; Monica Sciacco; Patrizia Ciscato; Andreina Bordoni; Silvana Tedeschi; Francesco Fortunato; Valeria Lucchini; Sara Bonato; Costanza Lamperti; Domenico Coviello; Yvan Torrente; Stefania Corti; Maurizio Moggio; Nereo Bresolin; Giacomo Pietro Comi
Journal:  J Neurol       Date:  2011-03-12       Impact factor: 4.849

10.  Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance.

Authors:  Kan N Hor; Wojciech Mazur; Michael D Taylor; Hussein R Al-Khalidi; Linda H Cripe; John L Jefferies; Subha V Raman; Eugene S Chung; Kathi J Kinnett; Katelyn Williams; William M Gottliebson; D Woodrow Benson
Journal:  J Cardiovasc Magn Reson       Date:  2011-10-19       Impact factor: 5.364

View more
  13 in total

1.  MicroRNA-29 overexpression by adeno-associated virus suppresses fibrosis and restores muscle function in combination with micro-dystrophin.

Authors:  Kristin N Heller; Joshua T Mendell; Jerry R Mendell; Louise R Rodino-Klapac
Journal:  JCI Insight       Date:  2017-05-04

2.  Left ventricular dysfunction in Duchenne muscular dystrophy.

Authors:  Katherine A James; Jane Gralla; Leslie A Ridall; ThuyQuynh N Do; Angela S Czaja; Peter M Mourani; Emma Ciafaloni; Christopher Cunniff; Jennifer Donnelly; Joyce Oleszek; Shree Pandya; Elinora Price; Michele L Yang; Scott R Auerbach
Journal:  Cardiol Young       Date:  2020-01-22       Impact factor: 1.093

3.  Diversity of Dystrophin Gene Mutations and Disease Progression in a Contemporary Cohort of Duchenne Muscular Dystrophy.

Authors:  Katheryn E Gambetta; Michael A McCulloch; Ashwin K Lal; Kenneth Knecht; Ryan J Butts; Chet R Villa; Jonathan N Johnson; Jennifer Conway; Matthew J Bock; Kurt R Schumacher; Sabrina P Law; Joshua M Friedland-Little; Shriprasad R Deshpande; Shawn C West; Irene D Lytrivi; Carol A Wittlieb-Weber
Journal:  Pediatr Cardiol       Date:  2022-01-22       Impact factor: 1.655

4.  Evaluation of the dystrophin carboxy-terminal domain for micro-dystrophin gene therapy in cardiac and skeletal muscles in the DMDmdx rat model.

Authors:  Audrey Bourdon; Virginie François; Liwen Zhang; Aude Lafoux; Bodvael Fraysse; Gilles Toumaniantz; Thibaut Larcher; Tiphaine Girard; Mireille Ledevin; Cyrielle Lebreton; Agnès Hivonnait; Anna Creismeas; Marine Allais; Basile Marie; Justine Guguin; Véronique Blouin; Séverine Remy; Ignacio Anegon; Corinne Huchet; Alberto Malerba; Betty Kao; Anita Le Heron; Philippe Moullier; George Dickson; Linda Popplewell; Oumeya Adjali; Federica Montanaro; Caroline Le Guiner
Journal:  Gene Ther       Date:  2022-02-01       Impact factor: 4.184

5.  Upper arm and cardiac magnetic resonance imaging in Duchenne muscular dystrophy.

Authors:  Lasya Gaur; Alexander Hanna; W Patricia Bandettini; Kenneth H Fischbeck; Andrew E Arai; Ami Mankodi
Journal:  Ann Clin Transl Neurol       Date:  2016-10-19       Impact factor: 4.511

6.  Progressive left ventricular dysfunction and long-term outcomes in patients with Duchenne muscular dystrophy receiving cardiopulmonary therapies.

Authors:  Mary Wang; David J Birnkrant; Dennis M Super; Irwin B Jacobs; Robert C Bahler
Journal:  Open Heart       Date:  2018-03-03

Review 7.  Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy.

Authors:  Dongsheng Duan
Journal:  Mol Ther       Date:  2018-07-17       Impact factor: 11.454

8.  Cardiac Dysfunction in Duchenne Muscular Dystrophy Is Less Frequent in Patients With Mutations in the Dystrophin Dp116 Coding Region Than in Other Regions.

Authors:  Tetsushi Yamamoto; Hiroyuki Awano; Zhujun Zhang; Mio Sakuma; Shoko Kitaaki; Masaaki Matsumoto; Masashi Nagai; Itsuko Sato; Takamitsu Imanishi; Nobuhide Hayashi; Masafumi Matsuo; Kazumoto Iijima; Jun Saegusa
Journal:  Circ Genom Precis Med       Date:  2018-01

9.  Protein Interaction Mapping related to Becker Muscular Dystrophy.

Authors:  Ali Azghar Peyvandi; Farshad Okhovatian; Majid Rezaei Tavirani; Mona Zamanian Azodi; Mostafa Rezaei Tavirani
Journal:  Iran J Child Neurol       Date:  2019

10.  Genotype-Phenotype Correlations in Duchenne and Becker Muscular Dystrophy Patients from the Canadian Neuromuscular Disease Registry.

Authors:  Kenji Rowel Q Lim; Quynh Nguyen; Toshifumi Yokota
Journal:  J Pers Med       Date:  2020-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.